← Leaderboards
Katherine Mary Dympna Bushby
University Of Rochester
$6,672,392
Attributed
$13,344,783
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.9M · FY2010–18$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$13,344,783 · 1
By mechanism
U01$13,344,783 · 1
Top collaborators
- Robert C Griggs7 shared
Most similar at University Of Rochester
Same institution · by research overlap
- Robert C Griggs$26,725,330
- Rabi Tawil$9,728,744
- Antti Seppo$860,101
- Martin S Zand$41,716,435
- Alok A Khorana$4,905,152
Others in their field
Top investigators on “Enrollment”
- Jeffrey P Krischer · University Of South Florida$370,021,822
- Lawrence Corey · Fred Hutchinson Cancer Center$329,293,433
- David R. Weir · University Of Michigan At Ann Arbor$265,368,888
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$231,949,330
- James Dennis Neaton · Northwestern University$218,104,551
- George R Seage · Abt Associates, Inc.$205,403,788
Research focus
EnrollmentInternationalComparative EfficacyEducational WorkshopFloorGenerationsAdrenal Cortex HormonesCollaborationsDeflazacortDouble-Blind MethodEvidence Based GuidelinesBoysFollow-UpFundingCaringAwardBaseClinical Trials UnitClient Satisfaction3-DimensionalBenefits And RisksDosageAdverse EffectsMulticenter Trials
Grant awards (7)
FOR-DMD: Double-blind randomized trial to optimize steroid regimen in Duchenne MD$1,228,519
U01 · FY2018 · NS
FOR-DMD: Double-blind randomized trial to optimize steroid regimen in Duchenne MD$1,412,277
U01 · FY2017 · NS
FOR-DMD: Double-blind randomized trial to optimize steroid regimen in Duchenne MD$1,946,015
U01 · FY2016 · NS
FOR-DMD:Double-blind randomized trial to optimize steroid regimen in Duchenne MD$1,811,776
U01 · FY2013 · NS
FOR-DMD:Double-blind randomized trial to optimize steroid regimen in Duchenne MD$1,500,000
U01 · FY2012 · NS
FOR-DMD:Double-blind randomized trial to optimize steroid regimen in Duchenne MD$1,500,000
U01 · FY2011 · NS
FOR-DMD:Double-blind randomized trial to optimize steroid regimen in Duchenne MD$3,946,196
U01 · FY2010 · NS